PDF herunterladen
Semin Respir Crit Care Med 2023; 44(04): 437-446
DOI: 10.1055/s-0043-1769616
Review Article

COVID-19-Related Pleural Diseases

Beenish Iqbal
1   Respiratory Trials Unit, Oxford Centre for Respiratory Disease, Oxford University Hospital, Oxford Centre for Respiratory Medicine, Churchill Hospital, NHS Trust, Oxford, United Kingdom
,
Najib M. Rahman
1   Respiratory Trials Unit, Oxford Centre for Respiratory Disease, Oxford University Hospital, Oxford Centre for Respiratory Medicine, Churchill Hospital, NHS Trust, Oxford, United Kingdom
2   Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
,
Rob J. Hallifax
1   Respiratory Trials Unit, Oxford Centre for Respiratory Disease, Oxford University Hospital, Oxford Centre for Respiratory Medicine, Churchill Hospital, NHS Trust, Oxford, United Kingdom
2   Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
› Institutsangaben
› Weitere Informationen
   Artikel einzeln kaufen Lizenzen und Reprints
Zoom Image

Abstract

Coronavirus disease 2019 (COVID-19)-related pleural diseases are now well recognized. Since the beginning of the pandemic, increasing cases of pleural diseases including pneumothorax, pneumomediastinum, and pleural effusion with severe COVID-19 infection have attracted the attention of physicians and are not incidental or due to barotrauma. The complicated course of COVID-19 illness highlights the complex pathophysiological underpinnings of pleural complications. The management of patients with pneumothorax and pneumomediastinum is challenging as the majority require assisted ventilation; physicians therefore appear to have a low threshold to intervene. Conversely, pleural effusion cases, although sharing some similar patient characteristics with pneumothorax and pneumomediastinum, are in general managed more conservatively. The evidence suggests that patients with COVID-19-related pleural diseases, either due to air leak or effusion, have more severe disease with a worse prognosis. This implies that prompt recognition of these complications and targeted management are key to improve outcomes.

Keywords

COVID-19 - pleural diseases - pneumothorax - pneumomediastinum - pleural effusion - complications


Publikationsverlauf

Artikel online veröffentlicht:
10. Juli 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA